Home/Filings/4/0001382963-17-000080
4//SEC Filing

RITTER PHARMACEUTICALS INC 4

Accession 0001382963-17-000080

$AIXCCIK 0001460702operating

Filed

May 11, 8:00 PM ET

Accepted

May 12, 4:38 PM ET

Size

5.0 KB

Accession

0001382963-17-000080

Insider Transaction Report

Form 4
Period: 2017-05-11
Step Michael D
DirectorCEO
Transactions
  • Purchase

    Common Stock

    2017-05-11$0.62/sh+13,000$8,00750,000 total(indirect: By Trust)
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6102 to $0.6199, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Issuer

RITTER PHARMACEUTICALS INC

CIK 0001460702

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001460702

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:38 PM ET
Size
5.0 KB